Tage Honore, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 30,000 shares at $8.03 ($241K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Open-market sale of $241k VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.